» Articles » PMID: 37435453

Visualization of the Protein-protein Interactions of Hormone Receptors in Hormone-dependent Cancer Research

Overview
Journal Endocr Oncol
Date 2023 Jul 12
PMID 37435453
Authors
Affiliations
Soon will be listed here.
Abstract

In hormone-dependent cancers, the activation of hormone receptors promotes the progression of cancer cells. Many proteins exert their functions through protein-protein interactions (PPIs). Moreover, in such cancers, hormone-hormone receptor binding, receptor dimerization, and cofactor mobilization PPIs occur primarily in hormone receptors, including estrogen, progesterone, glucocorticoid, androgen, and mineralocorticoid receptors. The visualization of hormone signaling has been primarily reported by immunohistochemistry using specific antibodies; however, the visualization of PPIs is expected to improve our understanding of hormone signaling and disease pathogenesis. Visualization techniques for PPIs include Förster resonance energy transfer (FRET) and bimolecular fluorescence complementation analysis; however, these techniques require the insertion of probes in the cells for PPI detection. Proximity ligation assay (PLA) is a method that could be used for both formalin-fixed paraffin-embedded (FFPE) tissue as well as immunostaining. It can also visualize hormone receptor localization and post-translational modifications of hormone receptors. This review summarizes the results of recent studies on visualization techniques for PPIs with hormone receptors; these techniques include FRET and PLA. In addition, super-resolution microscopy has been recently reported to be applicable to their visualization in both FFPE tissues and living cells. Super-resolution microscopy in conjunction with PLA and FRET could also contribute to the visualization of PPIs and subsequently provide a better understanding of the pathogenesis of hormone-dependent cancers in the future.

Citing Articles

Histopathological analysis potential for unveiling hormone signaling in endocrine-related tumors.

Miki Y, Iwabuchi E, Inoue C, Yamazaki Y, Suzuki T Endocr Oncol. 2024; 4(1):e240033.

PMID: 39246627 PMC: 11378131. DOI: 10.1530/EO-24-0033.


Fluorescence-based techniques for investigating estrogen receptor dynamics.

Han K, Choi G, Kim T BMB Rep. 2024; 57(11):472-483.

PMID: 39219049 PMC: 11608856.

References
1.
Vickman R, Franco O, Moline D, Vander Griend D, Thumbikat P, Hayward S . The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review. Asian J Urol. 2020; 7(3):191-202. PMC: 7385520. DOI: 10.1016/j.ajur.2019.10.003. View

2.
Hovland A, Powell R, Takimoto G, Tung L, Horwitz K . An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors. J Biol Chem. 1998; 273(10):5455-60. DOI: 10.1074/jbc.273.10.5455. View

3.
Soderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius K, Jarvius J . Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods. 2006; 3(12):995-1000. DOI: 10.1038/nmeth947. View

4.
Lozovyy V, Richardson L, Saade G, Menon R . Progesterone receptor membrane components: key regulators of fetal membrane integrity. Biol Reprod. 2020; 104(2):445-456. PMC: 7876665. DOI: 10.1093/biolre/ioaa192. View

5.
Cervantes-Badillo M, Paredes-Villa A, Gomez-Romero V, Cervantes-Roldan R, Arias-Romero L, Villamar-Cruz O . IFI27/ISG12 Downregulates Estrogen Receptor α Transactivation by Facilitating Its Interaction With CRM1/XPO1 in Breast Cancer Cells. Front Endocrinol (Lausanne). 2020; 11:568375. PMC: 7575815. DOI: 10.3389/fendo.2020.568375. View